Table 3 Number of patients with possible adverse events by treatment (% of valid responses to question)
SymptomNo (valid %) with symptom in albendazole groupNo (valid %) with symptom in placebo groupp Value for χ2 test
During 8 days of treatment
    Seizures2 (2.4)3 (3.5)1.00*
    Headache59 (70.2)53 (61.6)0.236
    Stomach problems (nausea, pain or vomiting)38 (45.2)40 (46.5)0.868
Intracranial hypertension0 (0)3 (0.5)0.246*
During first month following treatment
    Seizures8 (9.8)10 (12.0)0.637
    Headache50 (61.0)51 (61.4)0.951
    Stomach problems (nausea, pain or vomiting)9 (11.0)13 (15.7)0.376
    Intracranial hypertension0 (0)0 (0)NA

  • *Fisher’s exact test.